Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.

A recent BMC Medicine study assesses adherence to the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) recommendations and their impact on cancer incidence in the United Kingdom.

Study: Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study. Image Credit: Jo Panuwat D / Shutterstock.com Study: Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study. Image Credit: Jo Panuwat D / Shutterstock.com

Background

Various lifestyle factors, including physical activity, body composition, and diet, have been associated with the incidence of several types of cancers. In the U.K., about 40% of cancer cases are associated with modifiable risk factors, including obesity, tobacco smoking, alcohol consumption, and insufficient dietary fiber intake.

WCRF/AICR published ten Cancer Prevention Recommendations, which were updated in 2018, based on healthy lifestyle patterns to reduce the risk of cancer and other non-communicable diseases. Although several studies have assessed whether adherence to the WCRF/AICR Cancer Prevention Recommendations influenced cancer incidence and survival rates, most of these studies did not consider the most recent recommendations.

In the latest version, the previous recommendation of less salt consumption has been removed, and a limited intake of sugar-sweetened drinks has been included. In addition, a previous recommendation published in 2007 recommended a minimum consumption of 25 grams of dietary fiber daily, which was increased to at least 30 grams daily in the 2018 version.

A meta-analysis and systematic review documented significant adherence to the 2007 Cancer Prevention Recommendations that reduced the risk of colorectal, lung, and breast cancer. Greater adherence to the recommendations also reduced the overall cancer-specific mortality.

Importantly, different approaches were used to calculate adherence to the recommendations, which resulted in differential assessment outcomes. Therefore, there is a need for a standardized assessment to offer consistency and comparability between studies.

In this context, Shams-White and colleagues developed a standardized scoring system in 2019 that operationalized seven of the ten recommendations. However, few studies have used this system to assess adherence to the 2018 Cancer Prevention Recommendations.

About the study

The current U.K. Biobank prospective cohort study evaluated the association between adherence to 2018 WCRF/AICR Cancer Prevention Recommendations using a standardized fully operationalizing score and the risk of multiple cancers. To this end, the researchers assessed how diet, nutrition, and physical activity influenced the risk of all forms of invasive cancers, as well as fourteen specific cancers, including those affecting the uterus, bladder, gallbladder, colorectal, kidney, head and neck, breast, lungs, prostate, pancreas, esophagus, stomach, liver, and, ovaries.

The study cohort included over 500,000 participants recruited from 22 centers across England, Wales, and Scotland between 2006 and 2010. The U.K. Biobank cohort included participants between the ages of 37 and 73 years, about 56% female.

Study findings

A total of 94,778 UK Biobank participants were selected for the current study. During a median follow-up after 7.9 years, 7,296 participants were diagnosed with cancer, the most common of which was prostate, followed by breast and colorectal cancers.

A significant inverse correlation was observed between the total adherence score and the risk of all cancers. A 7% reduction in cancer risk was observed on every one-point increment in the score, which was adjusted for age, ethnicity, sex, smoking status, and deprivation.

Individuals with 3.75-4.25 point and 4.5–7 point score tertiles exhibited an 8% and 16% lower risk of developing all types of cancers, respectively. Likewise, one Swedish study indicated a 3% reduction in cancer risk for every one-point increment in score. These differential reduction values indicate the need to determine associations using the global population.

The current study estimated a 10% reduction in the risk of breast cancer on every one-point increment in adherence score. Individuals whose adherence score was between 5.75-7 points were at the lowest risk of breast cancer incidence.

A 10% reduction in incidence risk for colorectal cancer was observed for every one-point increment in score. For this type of cancer, participants belonging to the middle and highest score tertiles were at a lower risk of cancer incidence.

Greater adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations reduced the risk of esophageal, kidney, gallbladder, ovarian, and liver cancers. Consistent with the current study findings, a previous EPIC Study similarly indicated a 42% reduced risk of esophageal, kidney, and liver cancers following the 2007 version of the WCRF/AICR Cancer Prevention Recommendations.

Conclusions

The current study revealed that greater adherence to the 2018 version of WCRF/AICR Cancer Prevention Recommendations reduced the risk of different types of cancers, including ovarian, breast, kidney, gallbladder, colorectal, oesophageal, and liver cancers. These findings strongly support the 2018 WCRF/AICR Cancer Prevention Recommendations to prevent/reduce cancer incidence in the U.K.

In the future, similar studies should be conducted to assess the effectiveness of the recommendations on other global populations. However, these types of studies must incorporate a standardized methodology to enable comparability across studies.

Journal reference:
  • Malcomson, F. C., Parra-Soto, S., Ho, F. K., et al.  (2023) Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study. BMC Medicine 21(407). doi:10.1186/s12916-023-03107-y
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2023, November 30). Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20231130/Greater-adherence-to-lifestyle-based-recommendations-reduced-the-risk-of-cancers-in-the-UK.aspx.

  • MLA

    Bose, Priyom. "Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20231130/Greater-adherence-to-lifestyle-based-recommendations-reduced-the-risk-of-cancers-in-the-UK.aspx>.

  • Chicago

    Bose, Priyom. "Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.". News-Medical. https://www.news-medical.net/news/20231130/Greater-adherence-to-lifestyle-based-recommendations-reduced-the-risk-of-cancers-in-the-UK.aspx. (accessed December 22, 2024).

  • Harvard

    Bose, Priyom. 2023. Greater adherence to lifestyle-based recommendations reduced the risk of cancers in the U.K.. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20231130/Greater-adherence-to-lifestyle-based-recommendations-reduced-the-risk-of-cancers-in-the-UK.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PATINA trial demonstrates benefit of palbociclib in HR+ HER2+ metastatic breast cancer